Exploring tyrosine kinase inhibitors for HER2-positive breast cancer: comprehensive review on a complete pharmacology-molecular mechanisms, safety profiles, and insights from preclinical and clinical studies
{{output}}
Breast cancer involves complex molecular mechanisms, with elevated expression of various tyrosine kinase receptors correlating with unfavorable outcomes. Tyrosine kinase inhibitors are targeted cancer therapeutics that disrupt signaling pathways and inhibit ty... ...
